Sjoerd H den Uil
Overview
Explore the profile of Sjoerd H den Uil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nugteren S, den Uil S, Delis-van Diemen P, Simons-Oosterhuis Y, Lindenbergh-Kortleve D, van Haaften D, et al.
Sci Rep
. 2022 Jul;
12(1):12174.
PMID: 35842496
Secretory leukocyte protease inhibitor (SLPI) is a pleiotropic protein produced by healthy intestinal epithelial cells. SLPI regulates NF-κB activation, inhibits neutrophil proteases and has broad antimicrobial activity. Recently, increased SLPI...
2.
den Uil S, de Wit M, Slebos R, Delis-van Diemen P, Sanders J, Piersma S, et al.
Eur J Cancer
. 2020 Dec;
144:91-100.
PMID: 33341450
Aim: Better stratification of patients with stage II and stage III colon cancer for risk of recurrence is urgently needed. The present study aimed to validate the prognostic value of...
3.
den Uil S, van den Broek E, Coupe V, Vellinga T, Delis-van Diemen P, Bril H, et al.
BMC Gastroenterol
. 2019 Aug;
19(1):146.
PMID: 31420015
Background: Microvessel density (MVD), as a derived marker for angiogenesis, has been associated with poor outcome in several types of cancer. This study aimed to evaluate the prognostic value of...
4.
van den Broek E, den Uil S, Coupe V, Delis-van Diemen P, Bolijn A, Bril H, et al.
Oncotarget
. 2018 Jul;
9(50):29445-29452.
PMID: 30034629
Background: Colorectal cancer (CRC) is caused by genetic aberrations. is commonly involved in somatic focal DNA copy number losses, in more than one-third of CRCs. In this study, we aimed...
5.
den Uil S, Vermeulen E, Metz R, Rijbroek A, de Vries M
J Vasc Surg Cases Innov Tech
. 2018 Jun;
4(2):80-82.
PMID: 29942888
Nitrous oxide is a recreational drug gaining in popularity for its deemed innocence. However, side effects have recently been reported. In this case, a patient suffered major aortic arch thrombus...
6.
den Uil S, Coupe V, Linnekamp J, van den Broek E, Goos J, Delis-van Diemen P, et al.
Br J Cancer
. 2016 Nov;
115(12):1565-1574.
PMID: 27855440
Background: Colorectal cancer (CRC) is the third most common cancer worldwide. Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need. KCNQ1 was previously identified...
7.
van den Broek E, Krijgsman O, Sie D, Tijssen M, Mongera S, van de Wiel M, et al.
Oncotarget
. 2016 Oct;
7(45):73876-73887.
PMID: 27729614
Tumor profiling of DNA alterations, i.e. gene point mutations, somatic copy number aberrations (CNAs) and structural variants (SVs), improves insight into the molecular pathology of cancer and clinical outcome. Here,...
8.
Lenos K, Goos J, Vuist I, den Uil S, Delis-van Diemen P, Belt E, et al.
Oncotarget
. 2015 Jul;
6(28):26278-90.
PMID: 26172302
Colorectal cancer (CRC) is the third most prevalent cancer type worldwide with a mortality rate of approximately 50%. Elevated cell-surface expression of truncated carbohydrate structures such as Tn antigen (GalNAcα-Ser/Thr)...
9.
den Uil S, Thomassen I, Vermeulen E, Vuylsteke R, Stockmann H, de Vries M
Tumori
. 2014 Oct;
100(4):140e-3e.
PMID: 25296605
The incidence of melanoma has been increasing over the years and it remains, despite the heterogeneous survival for different stages, a disease with high mortality. Dissemination occurs primarily by the...